特一药业：公司正以止咳宝片为核心构建“1+N”产品矩阵

Core Viewpoint - The company, Te Yi Pharmaceutical, emphasizes the competitive advantages of its core product, Zhi Ke Bao tablets, which include technological, brand, and efficacy strengths [2]. Group 1: Competitive Advantages - Technological Advantage: The company utilizes advanced extraction processes and quantitative measurement techniques to ensure stable and controllable drug quality. It has applied for multiple invention patents related to the composition, preparation methods, and component testing of Zhi Ke Bao tablets, all of which have been granted, creating a comprehensive patent protection system [2]. - Brand Advantage: Zhi Ke Bao tablets have a century-long history and high market recognition, supported by a loyal customer base [2]. - Efficacy Advantage: Clinical validation shows that Zhi Ke Bao tablets are most effective for treating cold and phlegm-related coughs, with total effective rates of 100% and 95% respectively, while exhibiting low toxicity and quick results [2]. Group 2: Product Strategy - The company is building a "1+N" product matrix centered around Zhi Ke Bao tablets, aiming to continuously enrich its product line and further strengthen its core competitiveness [2].